RFA-AG-22-027: Grants for Early Medical/Surgical Specialists' Transition to Aging Research (GEMSSTAR) (R03 Clinical Trial Optional)
Closed
This grant is closed. A newer notice from the same program is open now: Grants for Early Medical/Surgical Specialists' Transition to Aging Research (GEMSSTAR) (R03 Clinical Trial Optional) (PAR-27-096). Status: Due dates in the notice, expires July 16, 2028. It is in our archive of National Institutes of Health notices from 2021.
National Institutes of Health offered grants to nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses. Applications closed on November 2, 2021.
From the official notice on Grants.gov, last changed July 6, 2021. Checked November 7, 2026.
- Award amountsNot given on Grants.gov
- Cost sharingNot required
- Funding typeGrant
About this NIH notice
- Activity codeR03
- Clinical trialsOptional
- Funded byNIA
- Median yearly award$161,000
- Typical project length2.5 years
- R03, Small Grant. A small, short project such as pilot work, a feasibility study, secondary data analysis or a new method, usually for up to two years. Other open R03 notices.
Projects funded under RFA-AG-22-027 were run by National Institute on Aging (NIA, 19 projects). Contact the program officer at the institute that fits your project before you apply; the notice lists them.
Application due dates, page limits and budget limits are set in the notice. Read RFA-AG-22-027 in the NIH Guide.
Other notices with this title
| Notice | Posted | Deadline | Status |
|---|---|---|---|
| PAR-27-096 | September 1, 2026 | Due dates in the notice, expires July 16, 2028 | Open |
| RFA-AG-25-021 | July 31, 2024 | Closed November 1, 2024 | Closed |
| RFA-AG-24-047 | June 12, 2023 | Closed October 30, 2023 | Closed |
| RFA-AG-23-031 | April 25, 2022 | Closed October 17, 2022 | Closed |
Key dates
| Posted | July 6, 2021 |
|---|---|
| Deadline | November 2, 2021 |
| Archived by Grants.gov | December 8, 2021 |
Who can apply
This opportunity was open to nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses.
All 15 applicant types the notice lists
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities/Indian housing authorities
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- For profit organizations other than small businesses
- Small businesses
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Is this a realistic fit?
- Most of the program's money (73% over five years) went to colleges and universities.
- No cost sharing or match is required.
What the grant funds
The goal of the GEMSSTAR program is to provide support for early-career physician-scientists trained in medical or surgical specialties or early-career dentist-scientists to launch careers as future leaders in aging- or geriatric-focused research. To achieve this goal, the GEMSSTAR Funding Opportunity Announcement (FOA) provides small grants to conduct transdisciplinary aging research that will yield pilot data and experience for subsequent aging research projects.
Funded under RFA-AG-22-027 so far
NIH funded 19 projects under RFA-AG-22-027 in fiscal 2022 to 2023, at 16 institutions. The median yearly award was $161,000.
| Project | Institution | Fiscal year | Award |
|---|---|---|---|
| Predicting Functional Decline and Clinical Outcomes in Newly Diagnosed Older Patients with Localized Bladder Cancer | University of Washington | 2023 | $143,606 |
| Predicting and Identifying Risk Factors for Short Time at Home in Older Adults after Hospitalization | Hebrew Rehabilitation Center for Aged | 2023 | $160,000 |
| Medication risks and challenges among people with dementia who live alone | University of California, San Francisco | 2023 | $161,500 |
| Trajectories of Frailty and Cognitive Impairment in Older Adults | University of Pennsylvania | 2023 | $162,500 |
| Role of Geroscience-Guided Therapeutics in Oral Health Problems of Aging | University of Nebraska Medical Center | 2023 | $153,500 |
| Age-related Changes in the Pulmonary Artery | Yale University | 2023 | $167,500 |
| Function, caregiving and adequacy of support before and after the transition to institutional settings | University of California, San Francisco | 2023 | $5,500 |
| Glycolysis and Alzheimer’s Disease | University of Iowa | 2023 | $154,500 |
Who has won Aging Research grants before
From fiscal 2021 to 2025, Aging Research (93.866) awarded $19 billion across 11,026 grant awards, an average of $1.7 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| The Regents of the University of California, San Francisco | California | 337 | $575 million |
| The Trustees of Columbia University in the City of New York | New York | 242 | $574 million |
| University of Southern California | California | 203 | $572 million |
| The Washington University | Missouri | 210 | $556 million |
| Regents of the University of Michigan | Michigan | 232 | $538 million |
Applying now
This notice no longer takes applications. Apply under the newer notice, PAR-27-096, which is open now.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is RFA-AG-22-027 still open?
No. It closed on November 2, 2021. A newer notice is open: PAR-27-096, due dates in the notice, expires July 16, 2028.
Who can apply for Grants for Early Medical/Surgical Specialists' Transition to Aging Research (GEMSSTAR) (R03 Clinical Trial Optional)?
National Institutes of Health accepted applications from nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses. The notice adds further conditions, so read its eligibility section.
What is the deadline for Grants for Early Medical/Surgical Specialists' Transition to Aging Research (GEMSSTAR) (R03 Clinical Trial Optional)?
Closed November 2, 2021. Applications are no longer accepted; the program's newer notices are on this page when there are any.
Who has been funded under RFA-AG-22-027?
NIH RePORTER lists 19 projects funded under RFA-AG-22-027 in fiscal 2022 to 2023, at 16 institutions. The most were at University of California, San Francisco, University of Pennsylvania, Yale University.
Who has won Aging Research grants before?
The largest recipients over five fiscal years were The Regents of the University of California, San Francisco, The Trustees of Columbia University in the City of New York, University of Southern California. The program made 11,026 awards worth $19 billion in that time.
Similar open grants
- Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional)
- Change of Recipient Organization (Type 7 Parent Clinical Trial Optional)
- Pilot Projects to Enhance the Human Virome Program (R03 Clinical Trials Not Allowed)
- Pilot Projects Investigating Understudied Proteins Associated with Rare Diseases (R03 Clinical Trial Not Allowed)
- Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed)
- NICHD Small Research Grant Program (R03 Clinical Trial Required)